<DOC>
	<DOCNO>NCT00821834</DOCNO>
	<brief_summary>Primary objective : - To evaluate whether 12 week clopidogrel superior ticlopidine term low risk safety event interest patient stable angina ( SA ) old myocardial infarction ( OMI ) percutaneous coronary intervention ( PCI ) plan . Secondary objective : - To compare incidence adverse event , adverse drug reaction bleed event patient treat clopidogrel versus ticlopidine . - To compare incidence major adverse cardiac event ( MACE ) major adverse cardiac cerebrovascular event ( MACCE ) patient treat clopidogrel versus ticlopidine . - To evaluate long-term safety ( adverse drug reaction , adverse event , safety event interest bleed event ) clopidogrel total 52 week ; - To evaluate MACE MACCE clopidogrel total 52 week .</brief_summary>
	<brief_title>Safety Evaluation Clopidogrel Sulfate Patients With Stable Angina/Old Myocardial Infarction Whom Percutaneous Coronary Intervention Being Planned</brief_title>
	<detailed_description>The study consist two period : - double blind treatment period 12 week follow , - open label clopidogrel treatment period subset patient . All patient receive aspirin ( 81-100 mg daily ) background therapy investigational product administration .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Stable Angina / Old Myocardial Infarction patient meet follow criterion : Myocardial ischemic finding proven within 2 month randomization , Either â‰¥ 75 % stenosis document CAG severe stenosis confirm multislice computerize tomography ( MSCT ) angiography within 1 month randomization , PCI plan . Planned coronary artery bypass graft ( CABG ) , emergent/urgent PCI , stag PCI , 3vessel coronary artery disease significant lesion vessel , Planned PCI associate 6 stent placement , Not less 50 % stenosis leave main coronary artery , Chronic total occlusion ( CTO ) , Saphenous vein graft ( SVG ) . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Old Myocardial infarction</keyword>
	<keyword>Platelet Aggregation Inhibitors</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Transluminal</keyword>
	<keyword>Percutaneous Coronary</keyword>
	<keyword>Stents</keyword>
</DOC>